Surgipath, based in Richmond, Illinois, is a well-established provider of consumables and medical

device accessories for clinical histology and research laboratories. Surgipath’s range of products

includes processing reagents, storage and specimen transport devices, cytology accessories and

safety products. These products will serve to complement and expand Leica Microsystems’ broad

histology product range.

John Monek, CEO of Surgipath, said that “the amalgamation of the product lines of both companies

gives the industry a comprehensive partner for all histology requirements. Leveraging the strengths of

both organizations will create further opportunity for the creation of innovative, high quality solutions.

That makes this acquisition an exciting prospect for both customers and employees worldwide.”

Similarly, Anne De Greef-Safft, President of Leica Microsystems’ Biosystems Division, said “this

acquisition is another significant step towards enabling the pathologist to achieve a more reliable

diagnosis. We are delighted to add Surgipath to our solutions portfolio.”

Leica Microsystems is a leading global designer and producer of innovative, high-tech, precision optical

systems for the analysis of microstructures as well as a broad product portfolio for histopathology. It is

one of the market leaders in the business areas Microscopy, Confocal Laser Scanning Microscopy with corresponding Imaging Systems, Specimen Preparation, and Medical Equipment. The company

manufactures a broad range of products for numerous applications requiring microscopic imaging,

measurement, and analysis. It also offers system solutions for life science including biotechnology and

medicine, research and development of raw materials, and industrial quality assurance. Furthermore,

Leica Microsystems brings histopathology labs and researchers the highest quality, most comprehensive product portfolio. The range includes the ideal product for each histology step and high-productivity workflow solutions for the entire lab, supporting better patient care through rapid turnaround, diagnostic confidence and close customer collaboration. The company is represented in over 100 countries with 10 manufacturing facilities in 8 countries, sales and service organizations in 19 countries and an international network of dealers. The international management is headquartered in Wetzlar, Germany.

Surgipath Medical Industries is a worldwide leader in the development, manufacture and supply of

quality product solutions for the Anatomical Pathology Laboratory. Since its foundation in 1976, the

fundamental business strategies have ensured the customers exceptional products, consistent supply,

optimal service, and competitive price levels. Beside the headquarters in Richmond, Illinois, USA

Surgipath has production sites in Eagle River, Wisconsin, USA, and Peterborough, UK as well as its

own direct sales organization. About 200 associates work for the company.